A 42-year-old man was found dead at home with bags of 'research chemicals' powders. Toxicological analysis identified three new psychoactive substances (NPS) in his system: 2-fluoro-deschloroketamine (2F-DCK), 3-methoxyeticyclidine (3-MeO-PCE), and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), each with purity above 95%. Peripheral blood concentrations were 1780 µg/L for 2F-DCK, 90 µg/L for 3-MeO-PCE, and 52 µg/L for 5-MeO-DMT. The death was attributed to respiratory depression from a 'cocktail effect' of these substances combined with amphetamine and cocaine. Hair analysis showed a pattern of addiction over several months. This case provides analytical data to aid interpretation in future forensic cases involving arylcyclohexylamine derivatives.
Thirteen metabolites of the dissociative drug 2-fluoro-deschloroketamine (2F-DCK) were produced in vitro using human liver microsomes and HepaRG liver cells. Seven additional metabolites, including three Phase II conjugates, were identified in post-mortem bile and urine from a fatal case. Molecular networking helped compare the two in vitro models, which proved complementary. The authors propose that nor-2F-DCK (mass-to-charge 208.1137) and a hydrogenated metabolite (224.1443) are reliable markers for detecting 2F-DCK use in high-resolution mass spectrometry libraries.